Neutralization of Clostridium difficile toxin B with V(H)H-Fc fusions targeting the delivery and CROPs domains

An increasing number of antibody-based therapies are being considered for controlling bacterial infections, including Clostridium difficile by targeting toxins A and B. In an effort to develop novel C. difficile immunotherapeutics, we previously isolated several single-domain antibodies (V(H)Hs) cap...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussack, Greg, Ryan, Shannon, van Faassen, Henk, Rossotti, Martin, MacKenzie, C. Roger, Tanha, Jamshid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291252/
https://www.ncbi.nlm.nih.gov/pubmed/30540857
http://dx.doi.org/10.1371/journal.pone.0208978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291252/
https://www.ncbi.nlm.nih.gov/pubmed/30540857
http://dx.doi.org/10.1371/journal.pone.0208978

Ejemplares similares